Intra Cellular Therapies - 株価

ITCI

33.32

毎日の変更:

1.94%

毎年:

34.03%

価格 日 年
Acadia Pharmaceuticals 52.83 0.82 1.58% 29.52%
Adamas Pharmaceuticals 4.72 0.21 4.66% -21.46%
ALKERMES 22.19 0.72 3.35% 21.59%
Aptinyx Inc 4.00 -0.02 -0.50% -13.04%
Arena Pharmaceuticals 77.68 1.02 1.33% 69.57%
BioCryst Pharmaceuticals 9.21 0.07 0.71% 207.00%
Biogen 269.44 -0.68 -0.25% -5.20%
Bristol-Myers Squibb 64.56 0.38 0.59% -3.45%
Cytokinetics 20.36 0.27 1.34% 60.82%
Esperion Therapeutics 25.93 0.48 1.89% -49.98%
Gilead Sciences 66.94 -0.04 -0.06% 4.69%
GW Pharmaceuticals 141.70 3.28 2.37% 22.26%
Halozyme Therapeutics 49.50 2.00 4.21% 151.72%
Intra Cellular Therapies 33.32 0.64 1.94% 34.03%
Jazz Pharmaceuticals 168.65 2.88 1.74% 13.07%
Johnson & Johnson 163.55 1.82 1.13% 10.11%
Marinus Pharmaceuticals 13.51 0.31 2.35% 500.44%
Neurocrine Biosciences 116.91 1.91 1.66% 14.42%
Minerva Neurosciences 3.28 0.09 2.82% -61.32%
Nektar Therapeutics 16.56 -0.10 -0.60% -23.93%
Novartis 96.90 0.02 0.02% 2.09%
Prothena 13.61 0.26 1.95% 1.49%
RedHill Biopharma 7.64 -0.12 -1.55% 28.84%
Supernus Pharmaceuticals 29.94 1.58 5.57% 23.67%
United Therapeutics 167.71 0.57 0.34% 84.56%
Vanda Pharmaceuticals 14.20 -0.35 -2.41% -5.33%
Zogenix 19.30 0.96 5.23% -64.47%

価格 日 年
NASDAQ 13543 12.15 0.09% 44.04%
Russell 2000 2168 27.34 1.28% 28.71%

ITCI:US
売上原価
EBIT
従業員
株当たりのEPS利益
売上総利益
時価総額
当期純利益
営業経費
販売および管理費
貿易債務者